Hyderabad: On Friday, Bharat Biotech announced its forthcoming acquisition of Chiron Behring Vaccines Pvt Ltd owned by GlaxoSmithKline Asia. After fulfilling a number of closing conditions, which Bharat Biotech and GSK intend to complete in the coming weeks, Bharat Biotech will acquire 100% equity stake in an all cash transaction.
from EenaduIndia | Business http://bit.ly/2S0hz21
from EenaduIndia | Business http://bit.ly/2S0hz21
Bharat Biotech acquires Chiron Behring Vaccines
Reviewed by placements page
on
February 15, 2019
Rating:

No comments: